Literature DB >> 31611641

Transportin-1 binds to the HIV-1 capsid via a nuclear localization signal and triggers uncoating.

Juliette Fernandez1, Anthony K Machado2, Sébastien Lyonnais3, Célia Chamontin1, Kathleen Gärtner2, Thibaut Léger4, Corinne Henriquet5, Camille Garcia4, Débora M Portilho2, Martine Pugnière5, Laurent Chaloin1, Delphine Muriaux3, Yohei Yamauchi6, Mickaël Blaise1, Sébastien Nisole1, Nathalie J Arhel7,8.   

Abstract

The initial steps of HIV replication in host cells prime the virus for passage through the nuclear pore and drive the establishment of a productive and irreparable infection1,2. The timely release of the viral genome from the capsid-referred to as uncoating-is emerging as a critical parameter for nuclear import, but the triggers and mechanisms that orchestrate these steps are unknown. Here, we identify β-karyopherin Transportin-1 (TRN-1) as a cellular co-factor of HIV-1 infection, which binds to incoming capsids, triggers their uncoating and promotes viral nuclear import. Depletion of TRN-1, which we characterized by mass spectrometry, significantly reduced the early steps of HIV-1 infection in target cells, including primary CD4+ T cells. TRN-1 bound directly to capsid nanotubes and induced dramatic structural damage, indicating that TRN-1 is necessary and sufficient for uncoating in vitro. Glycine 89 on the capsid protein, which is positioned within a nuclear localization signal in the cyclophilin A-binding loop, is critical for engaging the hydrophobic pocket of TRN-1 at position W730. In addition, TRN-1 promotes the efficient nuclear import of both viral DNA and capsid protein. Our study suggests that TRN-1 mediates the timely release of the HIV-1 genome from the capsid protein shell and efficient viral nuclear import.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31611641     DOI: 10.1038/s41564-019-0575-6

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  35 in total

1.  Measuring the subcellular compartmentalization of viral infections by protein complementation assay.

Authors:  Juliette Fernandez; Cédric Hassen-Khodja; Virginie Georget; Thierry Rose; Yves Jacob; Yves L Janin; Sébastien Nisole; Pierre-Olivier Vidalain; Nathalie J Arhel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

2.  HIV-1 capsids mimic a microtubule regulator to coordinate early stages of infection.

Authors:  Eveline Santos da Silva; Shanmugapriya Shanmugapriya; Viacheslav Malikov; Feng Gu; M Keegan Delaney; Mojgan H Naghavi
Journal:  EMBO J       Date:  2020-09-08       Impact factor: 11.598

3.  Dynactin 1 negatively regulates HIV-1 infection by sequestering the host cofactor CLIP170.

Authors:  Shanmugapriya Shanmugapriya; Eveline Santos da Silva; Jackson A Campbell; Marie-Philipe Boisjoli; Mojgan H Naghavi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

Review 4.  Teaching old dogmas new tricks: recent insights into the nuclear import of HIV-1.

Authors:  Adarsh Dharan; Edward M Campbell
Journal:  Curr Opin Virol       Date:  2022-02-01       Impact factor: 7.121

5.  Clinical targeting of HIV capsid protein with a long-acting small molecule.

Authors:  John O Link; Martin S Rhee; Winston C Tse; Jim Zheng; John R Somoza; William Rowe; Rebecca Begley; Anna Chiu; Andrew Mulato; Derek Hansen; Eric Singer; Luong K Tsai; Rujuta A Bam; Chien-Hung Chou; Eda Canales; Gediminas Brizgys; Jennifer R Zhang; Jiayao Li; Michael Graupe; Philip Morganelli; Qi Liu; Qiaoyin Wu; Randall L Halcomb; Roland D Saito; Scott D Schroeder; Scott E Lazerwith; Steven Bondy; Debi Jin; Magdeleine Hung; Nikolai Novikov; Xiaohong Liu; Armando G Villaseñor; Carina E Cannizzaro; Eric Y Hu; Robert L Anderson; Todd C Appleby; Bing Lu; Judy Mwangi; Albert Liclican; Anita Niedziela-Majka; Giuseppe A Papalia; Melanie H Wong; Stephanie A Leavitt; Yili Xu; David Koditek; George J Stepan; Helen Yu; Nikos Pagratis; Sheila Clancy; Shekeba Ahmadyar; Terrence Z Cai; Scott Sellers; Scott A Wolckenhauer; John Ling; Christian Callebaut; Nicolas Margot; Renee R Ram; Ya-Pei Liu; Rob Hyland; Gary I Sinclair; Peter J Ruane; Gordon E Crofoot; Cheryl K McDonald; Diana M Brainard; Latesh Lad; Swami Swaminathan; Wesley I Sundquist; Roman Sakowicz; Anne E Chester; William E Lee; Eric S Daar; Stephen R Yant; Tomas Cihlar
Journal:  Nature       Date:  2020-07-01       Impact factor: 49.962

Review 6.  Visualizing HIV-1 Capsid and Its Interactions with Antivirals and Host Factors.

Authors:  Morganne Wilbourne; Peijun Zhang
Journal:  Viruses       Date:  2021-02-04       Impact factor: 5.818

7.  Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core.

Authors:  Anastasia Selyutina; Mirjana Persaud; Lacy M Simons; Angel Bulnes-Ramos; Cindy Buffone; Alicia Martinez-Lopez; Viviana Scoca; Francesca Di Nunzio; Joseph Hiatt; Alexander Marson; Nevan J Krogan; Judd F Hultquist; Felipe Diaz-Griffero
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

8.  Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation.

Authors:  Qinfang Sun; Ronald M Levy; Karen A Kirby; Zhengqiang Wang; Stefan G Sarafianos; Nanjie Deng
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

Review 9.  The Role of Capsid in the Early Steps of HIV-1 Infection: New Insights into the Core of the Matter.

Authors:  Nawal AlBurtamani; Alwin Paul; Ariberto Fassati
Journal:  Viruses       Date:  2021-06-17       Impact factor: 5.048

10.  Alarmin S100A9 restricts retroviral infection by limiting reverse transcription in human dendritic cells.

Authors:  Ghizlane Maarifi; Justine Lagisquet; Quentin Hertel; Boris Bonaventure; Célia Chamontin; Kyra Fuchs; Olivier Moncorgé; Marine Tauziet; Margaux Mombled; Laure Papin; Jean-Pierre Molès; Charles Bodet; Nicolas Lévèque; Antoine Gross; Nathalie Arhel; Sébastien Nisole; Philippe Van de Perre; Caroline Goujon; Fabien P Blanchet
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.